Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rilpivirine”

130 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 130 results

Not applicableNot Yet RecruitingNCT05835635
What this trial is testing

Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine

Who this might be right for
Patient SatisfactionPatient PreferenceQuality of Life+1 more
Pontificia Universidad Catolica de Chile 50
Early research (Phase 1)Study completedNCT01336829
What this trial is testing

TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.

Who this might be right for
Hepatitis CHIV
Tibotec Pharmaceuticals, Ireland 33
Large-scale testing (Phase 3)Study completedNCT05917509
What this trial is testing

Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Who this might be right for
HIV Infections
ViiV Healthcare 171
Not applicableUnknownNCT06405464
What this trial is testing

Cabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort Study:Uptake, Outcome, and Risk Factors for Treatment Failures

Who this might be right for
HIV Infections
University of Zurich 600
Post-approval studies (Phase 4)UnknownNCT02404233
What this trial is testing

Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects

Who this might be right for
HIV Positive
Therapeutic Concepts 30
Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Large-scale testing (Phase 3)Study completedNCT01309243
What this trial is testing

Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 799
Not applicableLooking for participantsNCT06424964
What this trial is testing

Use of Long-Acting Injectable Cabotegravir/Rilpivirine for the Treatment of HIV in Belgium

Who this might be right for
Human Immunodeficiency Virus
Belgian Research on AIDS and HIV Consortium 600
Early research (Phase 1)Study completedNCT05112939
What this trial is testing

A Rilpivirine Extended-Release Suspension in Healthy Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 126
Post-approval studies (Phase 4)Study completedNCT01777997
What this trial is testing

FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 38
Testing effectiveness (Phase 2)Study completedNCT01286740
What this trial is testing

Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR

Who this might be right for
HIV-1 Infection
Gilead Sciences 50
Early research (Phase 1)Study completedNCT01031589
What this trial is testing

TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 19
Early research (Phase 1)Study completedNCT01593046
What this trial is testing

Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 43
Post-approval studies (Phase 4)Study completedNCT02042001
What this trial is testing

Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects

Who this might be right for
Impaired CognitionDepression/AnxietyPoor Quality Sleep+2 more
Azienda Ospedaliera San Gerardo di Monza 74
Post-approval studies (Phase 4)Study completedNCT04982445
What this trial is testing

Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) or Alternate Sites of Administration (ASA) in the United States (U.S.)

Who this might be right for
HIV Infections
ViiV Healthcare 44
Large-scale testing (Phase 3)Study completedNCT02104700
What this trial is testing

Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir

Who this might be right for
HIV
Philip Grant 150
Large-scale testing (Phase 3)Study completedNCT00540449
What this trial is testing

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Who this might be right for
HIV InfectionsHIV-1Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 694
Early research (Phase 1)Study completedNCT01288755
What this trial is testing

TMC278-TiDP6-C153 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC278 and Raltegravir

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 24
Early research (Phase 1)Study completedNCT03127189
What this trial is testing

Investigate the Effect of Different Particle Sizes on the Single-dose Pharmacokinetics of Rilpivirine After Intramuscular Injection of a Long-acting Nanosuspension in Healthy Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 110
Large-scale testing (Phase 3)Study completedNCT01252940
What this trial is testing

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Who this might be right for
HIV-1 Infection
Gilead Sciences 482
Next Page